The Latin American PV device market will see moderate growth through 2025, driven by endovascular procedure volume growth and rising PVD diagnosis rates, although cost constraints in the publicly funded health care system continue to hinder penetration of premium priced products such as DCBs and DES.
This Medtech 360 Report provides high-level market metrics for PV devices in Latin America, including country-level data for major countries and aggregate data for the rest of Latin America, across a 10-year period.
- Peripheral Vascular Devices - Market Insights - Latin America (Supplemental)
Author(s): Pankhil Gandhi, PharmD
Pankhil Gandhi is a research associate within the Cardiovascular Medtech Insights team at Decision Resources Group, specializing in transcatheter embolization and occlusion devices and deep venous disease treatment devices markets. Pankhil holds a Doctor of Pharmacy degree from the Babasaheb Ambedkar Marathwada University, Aurangabad.